What about postoperative pain?

Pain control, opioid abuse and medical expenses are issues of increasing concern in modern medicine

But recently, the United States has introduced new interventions to reduce the use of opioids and improve postoperative analgesia

The Enhanced Postoperative Recovery (ERA) program was introduced for the first time in the field of colorectal surgery

Although ERA original drug and bupivacaine liposomes have been independently proven to reduce the use of analgesics after breast reconstruction, there are limited data on the combined use of the two methods

Figure 1 Source of the article

Enhanced postoperative recovery (ERA) includes multiple interventions that have produced positive results in many surgical areas

The researchers retrospectively analyzed all patients who received DIEP flap treatment from January 2016 to December 2019

This type of intervention allows the comparison of three patient groups: before ERA, during ERA, and after ERA plus bupivacaine liposomes

Table 1 oral morphine equivalent length of stay and demographic statistics related disciplines factors univariate and multivariate linear regression

Table 2 Univariate and multiple linear regression of ERA components related to oral morphine equivalent and length of stay

The results showed that the pre-ERAS group consisted of 67 patients, the ERAS group consisted of 69 patients, and the ERAS plus bupivacaine liposome group consisted of 80 patients

In DIEP flap breast reconstruction, enhancing postoperative recovery can reduce postoperative opioid consumption and hospital stay

Original article:

Haddock Nicholas T,Garza Ricardo,Boyle Carolyn E et al.